논문/저서
https://www.ncbi.nlm.nih.gov/myncbi/1NqAvzcdnmpQw/bibliography/public/
<대표논문>
Defining the cellular and molecular
identities of histologic subtypes in lung adenocarcinoma
Exp Hematol Oncol. 2026 Jan 23;15(1):12. (교신저자)
Screening for Lung Cancer, Overdiagnosis,
and Healthcare Utilization: A Nationwide Population-Based Study
J Thorac Oncol. 2025 May;20(5):577-588. (공저자)
IL2-mediated modulation of small
extracellular vesicles secretion and PD-L1 expression: a novel perspective for
neutralizing immune suppression within cancer cells
Cancer Commun (Lond). 2024
Dec;44(12):1422-1426. (공저자)
Korean Real-World Data on Patients With
Unresectable Stage III NSCLC Treated With Durvalumab After Chemoradiotherapy:
PACIFIC-KR.
J Thorac Oncol. 2023 Aug;18(8):1042-1054. (공저자)
Dual Impact of IGF2 on Alveolar Stem Cell
Function during Tobacco-Induced Injury Repair and Development of Pulmonary
Emphysema and Cancer.
Cancer Res. 2023 Jun 2;83(11):1782-1799. (공저자)
Novel antitumor therapeutic strategy using
CD4+ T cell-derived extracellular vesicles.
Biomaterials. 2022 Oct;289:121765. (공저자)
Anti-angiogenesis revisited: reshaping the
treatment landscape of advanced non-small cell lung cancer.
Arch Pharm Res. 2022 Apr;45(4):263-279. (교신저자)
CD5L as an Extracellular Vesicle-Derived
Biomarker for Liquid Biopsy of Lung Cancer.
Diagnostics (Basel). 2021;11(4):620. (교신저자)
p63 and SOX2 Dictate Glucose Reliance and
Metabolic Vulnerabilities in Squamous Cell Carcinomas.
Cell Rep. 2019 Aug 13;28(7):1860-1878. (공저자)
Glucose Transporter 1 Gene Variants Predict
the Prognosis of Patients with Early-Stage Non-small Cell Lung Cancer.
Annals of surgical oncology. 2018;
25(11):3396-3403. (교신저자)
The distinct metabolic phenotype of lung
squamous cell carcinoma defines selective vulnerability to glycolytic
inhibition.
Nature communications. 2017; 8:15503. (제1저자)
Genetic polymorphisms in glycolytic pathway
are associated with the prognosis of patients with early stage non-small cell
lung cancer.
Scientific reports. 2016; 6:35603. (교신저자)
Polymorphisms in cancer-related pathway
genes and lung cancer.
The European respiratory journal. 2016;
48(4):1184-1191. (제1저자)
PD-L1 polymorphism can predict clinical
outcomes of non-small cell lung cancer patients treated with first-line
paclitaxel-cisplatin chemotherapy.
Scientific reports. 2016; 6:25952. (교신저자)
A genetic variation in microRNA target site
of KRT81 gene is associated with survival in early-stage non-small-cell lung
cancer.
Annals of oncology : official journal of
the European Society for Medical Oncology. 2015; 26(6):1142-8. (제1저자)
The influence of TP53 mutations on the
prognosis of patients with early stage non-small cell lung cancer may depend on
the intratumor heterogeneity of the mutations.
Molecular carcinogenesis. 2015;
54(2):93-101. (제1저자)
A functional polymorphism in CSF1R gene is
a novel susceptibility marker for lung cancer among never-smoking females.
Journal of thoracic oncology : official
publication of the International Association for the Study of Lung Cancer.
2014; 9(11):1647-55. (제1저자)
Polymorphisms in DNA repair and
apoptosis-related genes and clinical outcomes of patients with non-small cell
lung cancer treated with first-line paclitaxel-cisplatin chemotherapy.
Lung cancer (Amsterdam, Netherlands). 2013;
82(2):330-9. (제1저자)
Replication of results of genome-wide
association studies on lung cancer susceptibility loci in a Korean population.
Respirology (Carlton, Vic.). 2012;
17(4):699-706. (제1저자)
Somatic mutations in epidermal growth factor receptor signaling pathway genes in non-small cell lung cancers.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer. 2010; 5(11):1734-40. (제1저자)